Enteric Disease Testing Market Worth USD 5.86 Billion by 2035 | SNS Insider

The global Enteric Disease Testing Market is valued at USD 4.08 billion in 2025 and is projected to reach USD 5.86 billion by 2035, growing at a CAGR of 3.70%. Growth is driven by increasing foodborne and waterborne disease prevalence, rising demand for rapid pathogen detection, and expanding adoption of multiplex molecular diagnostics. North America and Europe are leading markets, with Asia-Pacific emerging as the fastest-growing region.

06/23/2026, 4:35 AM • GlobeNewswire

Global Automated Liquid Handling Systems Market Size/Share Worth USD 6.9 Billion by 2035 at a 9.8% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)

The global automated liquid handling systems market is valued at USD 2.7 billion in 2025 and is projected to reach USD 6.9 billion by 2035, growing at a CAGR of 9.8%. Growth is driven by increasing pharmaceutical R&D, clinical trials, technological advancements, and demand for automation in diagnostics and molecular testing. Key players include Eppendorf SE, PerkinElmer Inc., Thermo Fisher Scientific Inc., and QIAGEN NV.

06/18/2026, 10:30 PM • GlobeNewswire

QIAGEN INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. is Investigating Qiagen N.V. on Behalf of Qiagen Stockholders and Encourages Investors to Contact the Firm

Law firm Bragar Eagel & Squire is investigating Qiagen N.V. for potential securities law violations. The investigation was triggered after Qiagen's Q1 2026 results showed net sales declined 1% and QuantiFERON product sales fell 5%, contradicting the company's February guidance of 6-7% growth. The stock price dropped 11% following the announcement.

05/15/2026, 10:47 AM • GlobeNewswire

Global Cervical Cancer Diagnostics Market to Exhibit Growth at a CAGR of ~5% by 2034 | DelveInsight

The cervical cancer diagnostics market is projected to grow from USD 4.4 billion in 2025 to USD 7.1 billion by 2034 at a CAGR of ~5%. Growth is driven by rising cervical cancer prevalence, increasing adoption of advanced diagnostic technologies like HPV testing and AI-powered screening tools, government screening initiatives, and expanding healthcare infrastructure particularly in emerging economies. North America leads the market with 44% share in 2025.

05/14/2026, 1:00 PM • GlobeNewswire

Cancer Biomarkers Market Outlook 2026–2031: Growing at a 8.65% CAGR, Driven by Precision Oncology and Early Detection Demand, Says Mordor Intelligence

The cancer biomarkers market is projected to grow from USD 23.22 billion in 2026 to USD 35.16 billion by 2031, with a CAGR of 8.65%. Growth is driven by increasing cancer prevalence, rising adoption of personalized medicine, advancements in molecular diagnostics, and expanding use of companion diagnostics. North America leads the market while Asia-Pacific emerges as a high-growth region.

05/14/2026, 3:37 AM • GlobeNewswire

Global Colorectal Cancer Diagnostics and Therapeutics Market Anticipates Impressive Growth Trajectory at a CAGR of ~9% by 2034 | DelveInsight

The global colorectal cancer diagnostics and therapeutics market is projected to grow from USD 35 billion in 2025 to USD 73 billion by 2034 at a CAGR of ~9%. Growth is driven by rising colorectal cancer prevalence, increased screening awareness, advancements in non-invasive diagnostics (liquid biopsy, stool-based DNA tests), and emerging targeted therapies and immunotherapies. North America leads with 41% market share, while Asia-Pacific is the fastest-growing region.

05/13/2026, 1:00 PM • GlobeNewswire

Global HPV Testing and Pap Test Market is Expected to Showcase a Significant Growth at a CAGR of ~7% by 2034 | DelveInsight

The global HPV testing and Pap test market is projected to grow from USD 3.7 billion in 2025 to USD 6.5 billion by 2034, driven by rising cervical cancer prevalence, government screening initiatives, technological advancements, and the introduction of self-sampling tests. North America leads the market with 40.5% share, while Asia-Pacific emerges as a key growth hub.

05/12/2026, 1:00 PM • GlobeNewswire

QGEN Investors Have Opportunity to Join Qiagen N.V. Fraud Investigation with the Schall Law Firm

The Schall Law Firm is investigating Qiagen N.V. for potential securities violations, alleging the company issued false or misleading statements regarding QuantiFERON growth projections. Qiagen initially guided for 6-7% growth in February 2026 but revised guidance in April to indicate largely unchanged sales levels and normalized growth only in 2027, suggesting possible investor deception.

05/06/2026, 6:31 PM • GlobeNewswire

[Latest] Global Targeted DNA RNA Sequencing Market Size/Share Worth USD 46.9 Billion by 2035 at a 18.5% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)

The global Targeted DNA RNA Sequencing Market was valued at USD 8.6 billion in 2025 and is projected to reach USD 46.9 billion by 2035, growing at an 18.5% CAGR. Growth is driven by government genomic surveillance initiatives, pharmaceutical biomarker discovery, and rising demand for precision medicine. North America leads in market share while Asia Pacific shows the highest growth rate.

05/04/2026, 3:30 PM • GlobeNewswire

Global Metagenomics Sequencing Market to Register Stunning Growth at a CAGR of ~13% by 2034 | DelveInsight

The global metagenomics sequencing market is projected to grow from USD 2.5 billion in 2025 to USD 7.5 billion by 2034, driven by declining NGS costs, rising infectious disease burden, microbiome research expansion, and clinical diagnostic adoption. North America leads with 41% market share, while Asia-Pacific emerges as a major growth engine.

04/29/2026, 1:00 PM • GlobeNewswire

Coursera, Inc. Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses

Johnson Fistel, PLLP announced investigations into potential securities law violations by Coursera, Qiagen, and Domino's Pizza on behalf of affected investors. The Coursera investigation was triggered by the company's April 23, 2026 disclosure that its Coursera for Business segment underperformed expectations, with Enterprise growth lagging Consumer growth and facing continued demand and retention pressures, resulting in stock price decline.

04/28/2026, 9:54 PM • GlobeNewswire

Qiagen N.V. Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses

Law firm Johnson Fistel is investigating potential securities law violations on behalf of investors in Qiagen N.V., Domino's Pizza, Inc., and Hamilton Lane Incorporated. The investigation into Qiagen was triggered by the company's April 27, 2026 announcement of declining net sales (down 1% CER), reduced full-year 2026 outlook (1-2% growth), and a significant decline in immigration testing demand affecting its QuantiFERON product, which caused the stock to drop approximately 10%.

04/28/2026, 8:30 PM • GlobeNewswire

Global Next-Generation Sequencing (NGS) Market to Double in Size by 2030 - Asia-Pacific NGS Market Poised for Fastest Growth, Driven by Large-Scale Genomic Projects and the Rising Need for Precision Medicine

The global NGS market is projected to reach USD 29.53 billion by 2030 from USD 14.94 billion in 2025, growing at a CAGR of 14.6%. Growth is driven by expanding applications in oncology, infectious diseases, and precision medicine, with Asia-Pacific exhibiting the fastest regional growth. Consumables dominate the product segment, while academic and research institutes lead the services end-user segment.

04/10/2026, 5:45 AM • GlobeNewswire

Molecular Diagnostics Market Size is Expected to Reach USD 43.50 Billion by 2035 Owing to the Surging Demand for Accurate and Early Disease Detection Globally | SNS Insider

The global molecular diagnostics market is projected to grow from USD 18.26 billion in 2025 to USD 43.50 billion by 2035, with a CAGR of 9.07%. Growth is driven by increasing demand for early and accurate disease detection, rising prevalence of chronic diseases, and adoption of advanced technologies like PCR and next-generation sequencing. The U.S. market is expected to grow from USD 5.0 billion to USD 8.07 billion during the same period.

04/03/2026, 5:00 AM • GlobeNewswire

Molecular Diagnostics Market Outlook: Set to Grow at 10%+ CAGR Through 2031 as Precision Medicine and Genetic Testing Advance, Says Mordor Intelligence

The global molecular diagnostics market is projected to reach USD 33.51 billion by 2031, growing at a CAGR of 10.43% from 2026 to 2031. Growth is driven by increasing adoption of precision medicine, advancements in genomic testing technologies, and rising prevalence of infectious and chronic diseases. North America leads the market while Asia-Pacific is expected to be the fastest-growing region.

03/10/2026, 3:32 AM • GlobeNewswire